Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Eschalier

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Bulletin Du Cancer|January 15, 2003
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002)]Ivan Krakowski, Serge Theobald, Laurent Balp, et al.
Bioorganic Chemistry|August 8, 2021
Neuropathic pain-alleviating activity of novel 5-HT<sub>6</sub> receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamideMarcin Drop, Florian Jacquot, Vittorio Canale, et al.
Bulletin Du Cancer|November 12, 2003
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation]Sylvie Rostaing-Rigattieri, Hubert Rousselot, Ivan Krakowski, et al.
JMIR Formative Research|March 2, 2022
eDOL mHealth App and Web Platform for Self-monitoring and Medical Follow-up of Patients With Chronic Pain: Observational Feasibility StudyNicolas Kerckhove, Noémie Delage, Sébastien Cambier, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Bulletin Du Cancer|January 15, 2003
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002)]Ivan Krakowski, Serge Theobald, Laurent Balp, et al.
Bioorganic Chemistry|August 8, 2021
Neuropathic pain-alleviating activity of novel 5-HT<sub>6</sub> receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamideMarcin Drop, Florian Jacquot, Vittorio Canale, et al.
Bulletin Du Cancer|November 12, 2003
[Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation]Sylvie Rostaing-Rigattieri, Hubert Rousselot, Ivan Krakowski, et al.
JMIR Formative Research|March 2, 2022
eDOL mHealth App and Web Platform for Self-monitoring and Medical Follow-up of Patients With Chronic Pain: Observational Feasibility StudyNicolas Kerckhove, Noémie Delage, Sébastien Cambier, et al.
Pageof 15